
Dabrafenib + Trametinib in BRAF V600-Mutant Pediatric Low-Grade Glioma
Author(s) -
Warren Froelich
Publication year - 2022
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000856128.09599.bc
Subject(s) - trametinib , dabrafenib , mutant , glioma , cancer research , medicine , oncology , biology , melanoma , genetics , gene , kinase , mapk/erk pathway , metastatic melanoma , vemurafenib